← back to search

Jörg Haupenthal

Bioscience Research · US
Area of research
Molecular Biology · Molecular Medicine
Research interest
Research interests include Antibiotic Resistance in Bacteria, Bacterial biofilms and quorum sensing, Antimicrobial Peptides and Activities, and Tuberculosis Research and Epidemiology.
h-index
24
citations
2,283
works
112
NIH funding
primary concept
email

Recent publications

Clean Synthetic Strategies to Biologically Active Molecules from Lignin: A Green Path to Drug Discovery**
Angewandte Chemie International Edition 2023cited by 38position: middledoi
Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target‐Guided Synthesis
Angewandte Chemie International Edition 2022cited by 22position: middledoi
Biophysical Screening of a Focused Library for the Discovery of CYP121 Inhibitors as Novel Antimycobacterials
ChemMedChem 2017cited by 8position: middledoi
Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers
PLoS ONE 2013cited by 193position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Verena Köberle · University Hospital Frankfurt1 papers (2013–2013)Marie‐Sophie Schulze · Medizinische Hochschule Hannover1 papers (2023–2023)Giuseppe Allegretta · University of Notre Dame1 papers (2017–2017)Halvard Bönig · Goethe-Institute United Kingdom1 papers (2013–2013)Anna K. H. Hirsch · Medizinische Hochschule Hannover1 papers (2023–2023) · 1 papers (2017–2017)Bernd Kronenberger · Goethe University Frankfurt1 papers (2013–2013) · 1 papers (2023–2023)Sang‐Hyun Cho · University of Illinois Chicago1 papers (2017–2017) · 1 papers (2023–2023) · 1 papers (2017–2017) · 1 papers (2017–2017)Oliver Waidmann · Goethe University Frankfurt1 papers (2013–2013) · 1 papers (2023–2023)Ricardo M. Biondi · Universidad de Buenos Aires1 papers (2013–2013)Thomas Pleli · University Hospital Frankfurt1 papers (2013–2013)Eduardo Augusto Alonso · Goethe University Frankfurt1 papers (2013–2013) · 1 papers (2017–2017) · 1 papers (2017–2017) · 1 papers (2023–2023)